Validation of cofilin-1 as a biomarker in non-small cell lung cancer: Application of quantitative method in a retrospective cohort

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 9, 2011, Pages 1309-1316

  Müller, Carolina B ^a,b   De Barros, Rafael L S ^a,b   Castro, Mauro A A ^a   Lopes, Fernanda M ^a,b   Meurer, Rosalva T ^c   Roehe, Adriana ^c   Mazzini, Guilherme ^a   Ulbrich Kulczynski, Jane Maria ^d   Dal Pizzol, Felipe ^b,e   Fernandes, Marilda C ^c   Moreira, José C F ^a   Xavier, Léder L ^f   Klamt, Fábio ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b National Institute for Translational Medicine INCT TM   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^f PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Biomarker; Cofilin 1; Immunohistochemistry; Non small cell lung cancer; Prognosis

Indexed keywords

BIOLOGICAL MARKER; COFILIN 1;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; OPTICAL DENSITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; TUMOR BIOPSY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COFILIN 1; COHORT STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054775539     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1001-5     Document Type: Article

References (31)

1. Alberg AJ, Ford JG, Samet JM, American College of Chest Physicians (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. Chest 132(3 Suppl):29S-55S. doi:10.1378/chest.07-1347
2. Bernstein BW, Bamburg JR (2010) ADF/cofilin: a functional node in cell biology. Trends Cell Biol 20(4):187-195. doi:10.1016/j.tcb. 2010.01.001
3. Castro MA, Dal-Pizzol F, Zdanov S, Soares M, Müller CB, Lopes FM, Zanotto-Filho A, da Cruz Fernandes M, Moreira JC, Shacter E, Klamt F (2010) CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer. Cancer 116(15):3645-3655. doi:10.1002/cncr.25125
4. Cho WC (2007) Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed Pharmacother 61(9):515-519. doi:10.1016/j.biopha.2007.08.005 (Pubitemid 47570078)
5. Cregger M, Berger AJ, Rimm DL (2006) Immunohistochemistry and quantitative analysis of protein expression. Arch Pathol Lab Med 130(7):1026-1030 (Pubitemid 44061434)
6. De Matos LL, Stabenow E, Tavares MR, Ferraz AR, Capelozzi VL, Pinhal MA (2006) Immunohistochemistry quantification by a digital computer-assisted method compared to semiquantitative analysis. Clinics (Sao Paulo) 61(5):417-424. doi:10.1590/S18 07-59322006000500008 (Pubitemid 44639401)
7. Detterbeck FC, Boffa DJ, Tanoue LT (2009) The new lung cancer staging system. Chest 136(1):260-271. doi:10.1378/chest.08-0978
8. Gunnersen JM, Spirkoska V, Smith PE, Danks RA, Tan SS (2000) Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 32(2):146-154. doi: 10.1002/1098-1136 (200011) 32:2<146:AID-GLIA40>3.3. CO;2-V
9. Honig A, Rieger L, Kapp M, Dietl J, Kämmerer U (2005) Immunohistochemistry in human placental tissue-pitfalls of antigen detection. J Histochem Cytochem 53(11):1413-1420. doi:10.1369/jhc.5A6664.2005 (Pubitemid 41513073)
10. Issaq HJ, Waybright TJ, Veenstra TD (2011) Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis. doi:10.1002/elps.201000588
11. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J 60(5):277-300. doi:10.3322/caac.20073
12. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, Arenberg DA, Reddy RC, Akulapalli S, Thannickal VJ, Standiford TJ, Andrews PC, Omenn GS (2006) Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 5(5):1143-1154. doi:10.1021/pr050455t (Pubitemid 43727792)
13. Klamt F, Zdanov S, Levine RL, Pariser A, Zhang Y, Zhang B, Yu LR, Veenstra TD, Shacter E (2009) Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol 11(10):1241-1246. doi:10.1038/ncb1109-1387b
14. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Nonsmall cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584-594. doi:10.4065/83. 5.584 (Pubitemid 351720831)
15. Mountzios G, Dimopoulos MA, Soria JC, Sanoudou D, Papadimitriou CA (2009) Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: a review of published data. Crit Rev Oncol Hematol 75(2):94-109. doi: 10.1016/j.critrevonc.2009.10.002
16. Muller CB, de Barros RL, Moreira JC, Klamt F (2011) Bioinformatics approach for the validation of non-small cell lung cancer biomarkers. Front Biosci (Elite Ed) 1(3):46-50. doi:10.2741/e218
17. Nikliński J, Niklińska W, Laudanski J, Chyczewska E, Chyczewski L (2001) Prognostic molecular markers in non-small cell lung cancer. Lung Cancer 2:S53-S58. doi:10.1016/S0169-5002 (00) 80728-X (Pubitemid 33101846)
18. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93(14):1054-1061. doi:10.1093/jnci/93.14.1054 (Pubitemid 32717537)
19. Pérez-Soler R (2009) Individualized therapy in non-small-cell lung cancer: future versus current clinical practice. Oncogene 1:S38-S45. doi:10.1038/onc.2009.200
20. R Development Core Team (2009) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, http://www.R-project.org
21. Sawyers CL (2008) The cancer biomarker problem. Nature 452(7187):548-552. doi:10.1038/nature06913 (Pubitemid 351483368)
22. Sinha P, Hütter G, Köttgen E, Dietel M, Schadendorf D, Lage H (1999) Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by twodimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 20(14):2952-2960. doi:10.1002/(SICI) 1522-2683 (19991001) 20:14<2952:AID-ELPS2952>3.0. CO;2-H (Pubitemid 29517227)
23. Sung HJ, Cho JY (2008) Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 41(9):615-625. doi: 10.1586/14789450.6.1.27
24. Taylor CR, Levenson RM (2006) Quantification of immunohistochemistry- issues concerning methods, utility and semiquantitative assessment II. Histopathology 49(4):411-424. doi:10.1111/j. 1365-2559.2006.02513.x (Pubitemid 44401549)
25. van Rheenen J, Song X, van Roosmalen W, Cammer M, Chen X, Desmarais V, Yip SC, Backer JM, Eddy RJ, Condeelis JS (2007) EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. J Cell Biol 179(6):1247-1259. doi: 10.1083/jcb.200706206 (Pubitemid 350277742)
26. Walker RA (2006) Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology 49(4):406-410. doi:10.1111/j.1365-2559.2006. 02514.x (Pubitemid 44401548)
27. Wang W, Eddy R, Condeelis J (2007) The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7(6):429-440. doi:10.1038/nrc2148 (Pubitemid 46809168)
28. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ, Edwards BK (1999) Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91(8):675-690. doi:10.1093/jnci/91.8.675 (Pubitemid 29234561)
29. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, Netto CA, Achaval M (2005) A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protoc 16(1-3):58-64. doi:10.1016/j. brainresprot.2005.10.002 (Pubitemid 41774072)
30. Yuan K, Qian C, Zheng R (2009) Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer. Med Sci Monit 15(11):BR313-BR319
31. Zdanov S, Klamt F, Shacter E (2010) Importance of cofilin oxidation for oxidant-induced apoptosis. Cell Cycle 9(9):1675-1677. doi: 10.4161/cc.9.9.11650